Korydwen Terrasson, , , Ermias Mekuria Addo, , , Manead Khin, , , Tran Ngoc Ninh, , , Pankaj Pandey, , , Amar G. Chittiboyina, , , Daneel Ferreira, , , Harinantenaina L. Rakotondraibe, , , Joanna E. Burdette, , , Djaja D. Soejarto, , and , A. Douglas Kinghorn*,
{"title":"云南贝氏枝中具有细胞毒性的木脂素和类黄酮衍生物。","authors":"Korydwen Terrasson, , , Ermias Mekuria Addo, , , Manead Khin, , , Tran Ngoc Ninh, , , Pankaj Pandey, , , Amar G. Chittiboyina, , , Daneel Ferreira, , , Harinantenaina L. Rakotondraibe, , , Joanna E. Burdette, , , Djaja D. Soejarto, , and , A. Douglas Kinghorn*, ","doi":"10.1021/acs.jnatprod.5c00778","DOIUrl":null,"url":null,"abstract":"<p >An investigation of a cytotoxic MeOH extract of the branches of <i>Beilschmiedia yunnanensis</i>, collected in Vietnam, led to the isolation of four new compounds (<b>1</b>–<b>4</b>). Two of these, isolated from a CHCl<sub>3</sub>-soluble partition, were characterized as the furofuran-type neolignans, beilschmiedianins A (<b>1</b>)[(7<i>R</i>,7<i>′R</i>,8<i>S</i>,8′<i>S</i>,8″<i>R</i>)-4′,4″,9′′-trihydroxy-3,5,3′,3′′-tetramethoxy-4,8′′-oxy-7,9′:7′9-diepoxy-8,8′-sesquilignan-7′′-one)] and B (<b>2</b>) [(7<i>R</i>,7′<i>R</i>,7″<i>R</i>,8<i>S</i>,8′<i>S</i>,8″<i>R</i>)-9″-feruloyl-4′,4′′-dihydroxy-3,5,3′,3′′-tetramethoxy-4,8″-oxy-7,9′:7′,9-diepoxy-8,8′-dilignan-7″-ol]. In turn, the flavonoid glycosides <b>3</b> and <b>4</b> were obtained from an EtOAc-soluble partition and were assigned as (2<i>R</i>,3<i>R</i>)-dihydrokaempferol-5-<i>O</i>-β-<span>l</span>-arabinosyl-(2→1)-α-<span>l</span>-rhamnopyranoside and (2<i>R</i>,3<i>R</i>)-dihydrokaempferol-5-<i>O</i>-β-<span>l</span>-arabinopyranoside, respectively. The structures of these new compounds were determined using a combination of spectroscopic and spectrometric methods. Additionally, the known dilignan, (−)-9,9′-<i>O</i>-diferuloylsecoisolariciresinol (<b>5</b>), showed selective cytotoxicity against the OVCAR3 ovarian cancer cell line, with an IC<sub>50</sub> value of 0.51 μM. Mechanistic studies showed that compound <b>5</b> increased the cPARP levels and decreased the expression of BCL-2 in OVCAR3 cells.</p>","PeriodicalId":47,"journal":{"name":"Journal of Natural Products ","volume":"88 9","pages":"2158–2170"},"PeriodicalIF":3.6000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cytotoxic Lignan and Flavonoid Derivatives from the Branches of Beilschmiedia yunnanensis\",\"authors\":\"Korydwen Terrasson, , , Ermias Mekuria Addo, , , Manead Khin, , , Tran Ngoc Ninh, , , Pankaj Pandey, , , Amar G. Chittiboyina, , , Daneel Ferreira, , , Harinantenaina L. Rakotondraibe, , , Joanna E. Burdette, , , Djaja D. Soejarto, , and , A. Douglas Kinghorn*, \",\"doi\":\"10.1021/acs.jnatprod.5c00778\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >An investigation of a cytotoxic MeOH extract of the branches of <i>Beilschmiedia yunnanensis</i>, collected in Vietnam, led to the isolation of four new compounds (<b>1</b>–<b>4</b>). Two of these, isolated from a CHCl<sub>3</sub>-soluble partition, were characterized as the furofuran-type neolignans, beilschmiedianins A (<b>1</b>)[(7<i>R</i>,7<i>′R</i>,8<i>S</i>,8′<i>S</i>,8″<i>R</i>)-4′,4″,9′′-trihydroxy-3,5,3′,3′′-tetramethoxy-4,8′′-oxy-7,9′:7′9-diepoxy-8,8′-sesquilignan-7′′-one)] and B (<b>2</b>) [(7<i>R</i>,7′<i>R</i>,7″<i>R</i>,8<i>S</i>,8′<i>S</i>,8″<i>R</i>)-9″-feruloyl-4′,4′′-dihydroxy-3,5,3′,3′′-tetramethoxy-4,8″-oxy-7,9′:7′,9-diepoxy-8,8′-dilignan-7″-ol]. In turn, the flavonoid glycosides <b>3</b> and <b>4</b> were obtained from an EtOAc-soluble partition and were assigned as (2<i>R</i>,3<i>R</i>)-dihydrokaempferol-5-<i>O</i>-β-<span>l</span>-arabinosyl-(2→1)-α-<span>l</span>-rhamnopyranoside and (2<i>R</i>,3<i>R</i>)-dihydrokaempferol-5-<i>O</i>-β-<span>l</span>-arabinopyranoside, respectively. The structures of these new compounds were determined using a combination of spectroscopic and spectrometric methods. Additionally, the known dilignan, (−)-9,9′-<i>O</i>-diferuloylsecoisolariciresinol (<b>5</b>), showed selective cytotoxicity against the OVCAR3 ovarian cancer cell line, with an IC<sub>50</sub> value of 0.51 μM. Mechanistic studies showed that compound <b>5</b> increased the cPARP levels and decreased the expression of BCL-2 in OVCAR3 cells.</p>\",\"PeriodicalId\":47,\"journal\":{\"name\":\"Journal of Natural Products \",\"volume\":\"88 9\",\"pages\":\"2158–2170\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Natural Products \",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acs.jnatprod.5c00778\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Natural Products ","FirstCategoryId":"99","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.jnatprod.5c00778","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
摘要
一项从越南收集的Beilschmiedia yunnanensis分支中提取的细胞毒性MeOH提取物的研究,导致了四个新化合物的分离(1-4)。其中两个从chcl3可溶分区中分离得到,表征为呋喃型新木聚糖,beilschidiins a (1)[(7R,7'R,8S, 8S,8″R)-4',4″,9''-三羟基-3,5,3',3' -四甲基氧基-4,8' -氧基- 7,8 '-sesquilignan-7' - 1)]和B (2) [(7R,7',7' -二羟基-3,5,3',8″R)-9″-阿铁酰-4',4' -二羟基-3,5,3',3' -四甲基氧基-4,8″-氧基-7,9':7‘,9-二羟基-8,8’-二羟基- 7,8 '-二羟基- 7,8 '-二羟基- 7,8 '-二羟基- 7,8 '-二羟基- 7,8 '-二羟基- 7,8 '-二羟基- 7,8 '-二羟基- 7,8″-ol]。从乙酸乙酯可溶部分分离得到黄酮类苷3和4,分别命名为(2R,3R)-二氢山奈酚-5- o -β-l-阿拉伯糖基-(2→1)-α-l-鼠李糖苷和(2R,3R)-二氢山奈酚-5- o -β-l-阿拉伯糖吡喃苷。这些新化合物的结构是用光谱学和光谱法相结合的方法确定的。此外,已知的地木脂素(-)-9,9′- o -二亚戊醇醚异脂树脂醇(5)对OVCAR3卵巢癌细胞系表现出选择性的细胞毒性,IC50值为0.51 μM。机制研究表明,化合物5可提高OVCAR3细胞的cPARP水平,降低BCL-2的表达。
Cytotoxic Lignan and Flavonoid Derivatives from the Branches of Beilschmiedia yunnanensis
An investigation of a cytotoxic MeOH extract of the branches of Beilschmiedia yunnanensis, collected in Vietnam, led to the isolation of four new compounds (1–4). Two of these, isolated from a CHCl3-soluble partition, were characterized as the furofuran-type neolignans, beilschmiedianins A (1)[(7R,7′R,8S,8′S,8″R)-4′,4″,9′′-trihydroxy-3,5,3′,3′′-tetramethoxy-4,8′′-oxy-7,9′:7′9-diepoxy-8,8′-sesquilignan-7′′-one)] and B (2) [(7R,7′R,7″R,8S,8′S,8″R)-9″-feruloyl-4′,4′′-dihydroxy-3,5,3′,3′′-tetramethoxy-4,8″-oxy-7,9′:7′,9-diepoxy-8,8′-dilignan-7″-ol]. In turn, the flavonoid glycosides 3 and 4 were obtained from an EtOAc-soluble partition and were assigned as (2R,3R)-dihydrokaempferol-5-O-β-l-arabinosyl-(2→1)-α-l-rhamnopyranoside and (2R,3R)-dihydrokaempferol-5-O-β-l-arabinopyranoside, respectively. The structures of these new compounds were determined using a combination of spectroscopic and spectrometric methods. Additionally, the known dilignan, (−)-9,9′-O-diferuloylsecoisolariciresinol (5), showed selective cytotoxicity against the OVCAR3 ovarian cancer cell line, with an IC50 value of 0.51 μM. Mechanistic studies showed that compound 5 increased the cPARP levels and decreased the expression of BCL-2 in OVCAR3 cells.
期刊介绍:
The Journal of Natural Products invites and publishes papers that make substantial and scholarly contributions to the area of natural products research. Contributions may relate to the chemistry and/or biochemistry of naturally occurring compounds or the biology of living systems from which they are obtained.
Specifically, there may be articles that describe secondary metabolites of microorganisms, including antibiotics and mycotoxins; physiologically active compounds from terrestrial and marine plants and animals; biochemical studies, including biosynthesis and microbiological transformations; fermentation and plant tissue culture; the isolation, structure elucidation, and chemical synthesis of novel compounds from nature; and the pharmacology of compounds of natural origin.
When new compounds are reported, manuscripts describing their biological activity are much preferred.
Specifically, there may be articles that describe secondary metabolites of microorganisms, including antibiotics and mycotoxins; physiologically active compounds from terrestrial and marine plants and animals; biochemical studies, including biosynthesis and microbiological transformations; fermentation and plant tissue culture; the isolation, structure elucidation, and chemical synthesis of novel compounds from nature; and the pharmacology of compounds of natural origin.